These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 16101428)
21. FK409, a new nitric-oxide donor, suppresses smooth muscle proliferation in the rat model of balloon angioplasty. Seki J; Nishio M; Kato Y; Motoyama Y; Yoshida K Atherosclerosis; 1995 Sep; 117(1):97-106. PubMed ID: 8546759 [TBL] [Abstract][Full Text] [Related]
22. Cardiohemodynamic effect of FK409, a novel highly potent nitrovasodilator, in anesthetized dogs. Yamada H; Yoneyama F; Satoh K; Taira N Eur J Pharmacol; 1991 Nov; 205(1):81-3. PubMed ID: 1812001 [TBL] [Abstract][Full Text] [Related]
23. Nitric oxide donor FK409 and 8-bromoguanosine-cyclic monophosphate attenuate cardiac contractility assessed by Emax. Hiraga H; Okubo T; Suto N; Yamamoto T; Yoshida IM; Okumura K Fundam Clin Pharmacol; 2001 Apr; 15(2):125-34. PubMed ID: 11468022 [TBL] [Abstract][Full Text] [Related]
24. FK409, a spontaneous nitric oxide releaser, attenuates allograft vasculopathy in a rat aortic transplant model. Fukada J; Schena S; Tack I; Ruiz P; Kurimoto Y; Pang M; Aitouche A; Abe T; Striker LJ; Pham SM Circ Res; 2000 Jul; 87(1):66-72. PubMed ID: 10884374 [TBL] [Abstract][Full Text] [Related]
25. Nitrosyl-cobinamide, a new and direct nitric oxide releasing drug effective in vivo. Broderick KE; Alvarez L; Balasubramanian M; Belke DD; Makino A; Chan A; Woods VL; Dillmann WH; Sharma VS; Pilz RB; Bigby TD; Boss GR Exp Biol Med (Maywood); 2007 Dec; 232(11):1432-40. PubMed ID: 18040067 [TBL] [Abstract][Full Text] [Related]
27. Renal hemodynamic and excretory responses in anesthetized rats to FK409, a novel nitric oxide donor. Urabe K; Matsumura Y; Nishiura M; Maeda K; Morimoto S Eur J Pharmacol; 1997 Feb; 321(2):195-200. PubMed ID: 9063688 [TBL] [Abstract][Full Text] [Related]
28. Acceleration of nitric oxide (NO) release from FK409, a spontaneous NO releaser, in the presence of sulfhydryl-bearing compounds. Fukuyama S; Hirasawa Y; Cox D; Koda S; Kita Y Pharm Res; 1995 Dec; 12(12):1948-52. PubMed ID: 8786971 [TBL] [Abstract][Full Text] [Related]
29. Comparison of antiplatelet effects of two nitric oxide-donating agents, FR146801 and FK409. Hirasawa Y; Kato Y; Fukuyama S; Ohno M; Nishino S; Kato M; Kita Y Thromb Haemost; 1998 Mar; 79(3):620-4. PubMed ID: 9531052 [TBL] [Abstract][Full Text] [Related]
30. Nitric oxide (NO)-releasing pathway of FK409 in the presence of sulfhydryl-bearing compounds. Fukuyama S; Azuma T; Hirasawa Y; Morokoshi N; Akama T; Koda S; Kita Y Pharm Res; 1996 Aug; 13(8):1238-42. PubMed ID: 8865319 [TBL] [Abstract][Full Text] [Related]
31. In vitro effects of new generation fungal derived nitric oxide donors on rabbit basilar artery. Islam MS; Ohkuma H; Kimura M; Suzuki S Neurol Med Chir (Tokyo); 2003 Apr; 43(4):175-80; discussion 180. PubMed ID: 12760495 [TBL] [Abstract][Full Text] [Related]
32. Protective effect of FK409, a spontaneous nitric oxide releaser, on ischemic acute renal failure in rats. Matsumura Y; Nishiura M; Deguchi S; Hashimoto N; Ogawa T; Seo R J Pharmacol Exp Ther; 1998 Dec; 287(3):1084-91. PubMed ID: 9864296 [TBL] [Abstract][Full Text] [Related]
33. Oral biological activities of spontaneous nitric oxide releasers are accounted for by their nitric oxide-releasing rates and oral absorption manners. Kita Y; Hirasawa Y; Fukuyama S; Ohkubo K; Kato Y; Takamatsu H; Ohno M; Nishino S; Kato M; Seki J J Pharmacol Exp Ther; 1996 Feb; 276(2):421-5. PubMed ID: 8632305 [TBL] [Abstract][Full Text] [Related]
34. A spontaneous nitric oxide donor ameliorates small bowel ischemia-reperfusion injury in dogs. Kawata K; Takeyoshi I; Iwanami K; Sunose Y; Aiba M; Ohwada S; Matsumoto K; Morishita Y Dig Dis Sci; 2001 Aug; 46(8):1748-56. PubMed ID: 11508678 [TBL] [Abstract][Full Text] [Related]
35. FK409, a novel vasodilator isolated from the acid-treated fermentation broth of Streptomyces griseosporeus. III. Reaction mechanism and synthesis. Hino M; Takase S; Itoh Y; Uchida I; Okamoto M; Kohsaka M; Aoki H; Imanaka H J Antibiot (Tokyo); 1989 Nov; 42(11):1589-92. PubMed ID: 2584142 [TBL] [Abstract][Full Text] [Related]
36. Effects of FK409 on intestinal ischemia-reperfusion injury and ischemia-induced changes in the rat mucosal villus microcirculation. Kalia N; Pockley AG; Wood RF; Brown NJ Transplantation; 2001 Dec; 72(12):1875-80. PubMed ID: 11773883 [TBL] [Abstract][Full Text] [Related]
37. Antiplatelet activities of FK409, a new spontaneous NO releaser. Kita Y; Hirasawa Y; Yoshida K; Maeda K Br J Pharmacol; 1994 Oct; 113(2):385-8. PubMed ID: 7834188 [TBL] [Abstract][Full Text] [Related]
38. The in vitro pulmonary vascular effects of FK409 (nitric oxide donor): a study in normotensive and pulmonary hypertensive rats. Wanstall JC; Kaye JA; Gambino A Br J Pharmacol; 1997 May; 121(2):280-6. PubMed ID: 9154338 [TBL] [Abstract][Full Text] [Related]